Welcome to the 7th CUHK Sarcoma Masterclass!

The science of sarcomas has advanced rapidly in the last decade. The heterogeneity and complexity of this disease have highlighted the importance of a multidisciplinary team approach to achieve better treatment outcomes. As an academic institution and a quaternary referral centre for Sarcoma care in Hong Kong, The Chinese University of Hong Kong (CUHK) and Prince of Wales Hospital (PWH) have established an Adult Sarcoma Multidisciplinary Tumor Board (MDT) since 2012. In recent years, we have continued to advance our collaborative efforts between various disciplines.

This one-day incentive and interactive workshop will comprise of both didactic lectures and case discussions on practical aspects and latest advances in multidisciplinary sarcoma management. Faculty members of this workshop are all active and experienced members of the CUHK/PWH Adult Sarcoma MDT, as well as other hospitals and institutions in Hong Kong. We are especially delighted to have Dr. David J. Papke from Harvard Medical School to join us at this year’s event. Dr. Papke will share with us his insight on Next Generation Sequencing and Next Generation Immunohistochemistry in Sarcoma Diagnostics.

The overriding aim of this event is to promote multidisciplinary sarcoma care, and we also look forward to hearing your opinions, views and practices in your home country. We hope that this event can also provide some face-to-face and networking time between attendees, to further enhance collaborations within the Asia-Pacific region.

We are grateful to our industry partners including (in alphabetical order) Amgen Hong Kong Limited, Eisai (HK) Co Ltd, Roche Hong Kong Limited and Zai Lab (Hong Kong) Limited for providing their kind support towards this masterclass, without which this event would not have been possible.

We trust that you will find today’s event of great interest.